All In Biotech

Drug Trial Radar · NCT00002611

Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer

NATIONAL WILMS TUMOR STUDY-5 -- THERAPEUTIC TRIAL AND BIOLOGY STUDY

Last checked: Nov 19, 2026Latest source record: Feb 25, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,031

Actual

Start

Jul 1995

Primary completion

Jun 2002

Study completion Aug 2003

Sponsor

Lead sponsor
Children's Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Jan 27, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Who can join
All sexes, from 0 years, up to 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high energy x-rays to damage tumor cells. It is not yet known whether combination chemotherapy alone or combination chemotherapy plus radiation therapy is more effective for childhood kidney cancer. PURPOSE: Phase III trial to compare the effectiveness of combination chemotherapy with or without radiation therapy in treating children who have kidney cancer.

Conditions

  • Kidney Cancer

Interventions

  • dactinomycinBiological

  • filgrastimBiological

  • cyclophosphamideDrug

  • doxorubicin hydrochlorideDrug

    Source and Pharmacology: An anthracycline antibiotic isolated from cultures of Streptomyces peucetius. Binds to DNA and inhibits nucleic acid synthesis, with its major lethal effect occurring during the S phase of the cell cycle. Has some topoisomerase II inhibitory activity. Since it is primarily excreted by the liver, any liver impairment may enhance toxicity. 40% to 50% is excreted in the bile; \<5% in the urine. The drug has a very short initial t½ of \<20 minutes and a terminal t½ of 17 hours. Animal studies indicate cytotoxic levels persist in tissue for as long as 24 hours.

  • etoposideDrug

  • vincristine sulfateDrug

  • conventional surgeryProcedure

  • radiation therapyRadiation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression free survival

Locations

235 sites in 7 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Comprehensive Cancer Center

    Birmingham, Alabama

  • University of South Alabama Medical Center

    Mobile, Alabama

  • Phoenix Children's Hospital

    Phoenix, Arizona

  • Arizona Cancer Center

    Tucson, Arizona

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Southern California Permanente Medical Group

    Downey, California

  • City of Hope Comprehensive Cancer Center

    Duarte, California

  • Rebecca and John Moores UCSD Cancer Center

    La Jolla, California

  • Loma Linda University Medical Center

    Loma Linda, California

  • Jonathan Jaques Children's Cancer Center

    Long Beach, California

  • Children's Hospital Los Angeles

    Los Angeles, California

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • Jonsson Comprehensive Cancer Center, UCLA

    Los Angeles, California

  • Children's Hospital Central California

    Madera, California

  • Children's Hospital of Oakland

    Oakland, California

  • Chao Family Comprehensive Cancer Center

    Orange, California

  • Children's Hospital of Orange County

    Orange, California

  • Lucile Packard Children's Hospital at Stanford

    Palo Alto, California

  • Sutter Cancer Center

    Sacramento, California

  • University of California Davis Medical Center

    Sacramento, California

  • Kaiser Permanente Medical Center/Kaiser Foundation Hospital - San Diego

    San Diego, California

  • Children's Hospital San Diego

    San Diego, California

  • Kaiser Permanente Medical Center - San Francisco Geary Campus

    San Francisco, California

  • UCSF Comprehensive Cancer Center

    San Francisco, California

  • Santa Barbara Cottage Hospital

    Santa Barbara, California

  • Kaiser Permanente Medical Center - Santa Clara

    Santa Clara, California

  • David Grant Medical Center

    Travis Air Force Base, California

  • Children's Hospital of Denver

    Denver, Colorado

  • Childhood Hematology/Oncology Associates

    Denver, Colorado

  • Presbyterian-St Luke's Medical Center

    Denver, Colorado

  • University of Connecticut Health Center

    Farmington, Connecticut

  • Yale Comprehensive Cancer Center

    New Haven, Connecticut

  • Alfred I. Dupont Institute

    Wilmington, Delaware

  • Lombardi Cancer Center

    Washington D.C., District of Columbia

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Walter Reed Army Medical Center

    Washington D.C., District of Columbia

  • Broward General Medical Center

    Fort Lauderdale, Florida

  • Children's Hospital of Southwest Florida

    Fort Myers, Florida

  • Shands Hospital and Clinics, University of Florida

    Gainesville, Florida

  • Joe DiMaggio Children's Hospital at Memorial

    Hollywood, Florida

Showing 40 of 235 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.